Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Vomiting 6 Postoperative Nausea and Vomiting 3 Neoplasms 3 Prostatic Neoplasms 1 Pain, Postoperative 1 Ovarian Neoplasms 1 Nausea 1 Myofibroma 1 Lung Neoplasms 1 Hematologic Neoplasms 1 Colonic Neoplasms 1 Agnosia 1 Adenomyosis 1

Interventions

Dexamethasone 29 Aprepitant 24 Palonosetron 20 Ondansetron 20 Calcium Dobesilate 13 Olanzapine 12 Granisetron 11 Therapeutics 7 fosaprepitant 6 Doxorubicin 6 Cyclophosphamide 6 dexamethasone acetate 5 netupitant 4 Vincristine 4 dolasetron 3 Yoga 3 Tropisetron 3 Surveys and Questionnaires 3 Psychiatric Rehabilitation 3 Prochlorperazine 3 Metoclopramide 3 Lorazepam 3 Dronabinol 3 Acupressure 3 peppermint oil 2 netupitant, palosentron drug combination 2 ginger extract 2 dexamethasone 21-phosphate 2 Sugars 2 Rituximab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Nausea × ramosetron × Clear all

NCT01046461 2012-02-17

RAD

Hallym University Medical Center

Phase 2 Unknown

Nausea, Neoplasms, Vomiting, Postoperative Nausea and Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡